Fibromyalgia is a complex condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and cognitive issues. Despite affecting millions worldwide, fibromyalgia remains poorly understood, and treatment options often provide limited relief. However, amidst the myriad of therapies, one promising approach has been gaining attention in recent years: Hyperbaric Oxygen Therapy (HBOT).
HBOT involves breathing pure oxygen in a pressurized chamber, allowing the lungs to gather more oxygen than would be possible breathing pure oxygen at normal air pressure. This oxygen-rich environment promotes healing by increasing oxygen delivery to tissues throughout the body, including areas with poor circulation or inflammation. While traditionally used to treat conditions such as decompression sickness and non-healing wounds, HBOT’s potential in managing fibromyalgia symptoms has sparked considerable interest.
Understanding Fibromyalgia
Before delving into HBOT’s potential benefits, it’s crucial to grasp the multifaceted nature of fibromyalgia. This condition involves dysregulation of the central nervous system, leading to heightened pain sensitivity and abnormal processing of pain signals. Additionally, factors like inflammation, oxidative stress, and mitochondrial dysfunction contribute to the symptomatology, making fibromyalgia a challenging condition to manage effectively.
How HBOT Works in Fibromyalgia
- Oxygenation of Tissues: Fibromyalgia patients often exhibit reduced tissue oxygenation, exacerbating symptoms like fatigue and muscle pain. HBOT saturates tissues with oxygen, potentially alleviating these symptoms by enhancing cellular metabolism and reducing tissue hypoxia.
- Anti-inflammatory Effects: Chronic inflammation is a hallmark of fibromyalgia, contributing to pain amplification and systemic symptoms. HBOT has demonstrated anti-inflammatory properties, modulating inflammatory cytokines and promoting tissue repair, which may help mitigate fibromyalgia-associated inflammation.
- Neurological Modulation: Fibromyalgia involves dysregulated pain processing within the central nervous system. HBOT has been shown to influence neuronal activity, restoring neural function and potentially attenuating pain perception in fibromyalgia patients.
- Enhanced Cellular Function: Mitochondrial dysfunction is implicated in fibromyalgia, leading to impaired energy production and increased oxidative stress. HBOT improves mitochondrial function, enhances ATP production, and reduces oxidative damage, addressing fundamental cellular abnormalities associated with fibromyalgia.
Clinical Evidence and Research
While research on HBOT specifically for fibromyalgia is still evolving, preliminary studies suggest promising outcomes.
A recent study in 2022 found that HBOT might have a positive effect in improving pain, tender points, fatigue, multidimensional function, patient global and sleep disturbance in patients with fibromyalgia.
https://bmjopen.bmj.com/content/13/1/e062322
Another study in 2015 found that HBOT can improve the symptoms and life quality of fibromyalgia patients. The study showed that HBOT can significantly rectify abnormal brain activity in pain related areas and that HBOT can induce neuroplasticity in individuals with fibromyalgia.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444341